Blueprint Medicines Corp·4

Mar 28, 5:22 PM ET

Blueprint Medicines Corp 4

4 · Blueprint Medicines Corp · Filed Mar 28, 2016

Insider Transaction Report

Form 4
Period: 2016-03-24
Lengauer Christoph
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2016-03-24$1.87/sh+6,668$12,46991,382 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2016-03-246,668134,316 total
    Exercise: $1.87Exp: 2024-08-14Common Stock (6,668 underlying)
  • Exercise/Conversion

    Common Stock

    2016-03-24$1.49/sh+12,499$18,56184,714 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2016-03-2412,499140,984 total
    Exercise: $1.49Exp: 2023-11-03Common Stock (12,499 underlying)
Footnotes (2)
  • [F1]This option vests in 48 equal monthly installments beginning on November 1, 2013.
  • [F2]This option vests in 48 equal monthly installments beginning on August 18, 2014.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -